What is the best pharmacotherapeutic strategy for HER-2 positive breast cancer?

Gaia Giannone, Andrea Milani, Elena Geuna, Danilo Galizia, Federica Biello, Filippo Montemurro

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)1-5
Number of pages5
JournalExpert Opinion on Pharmacotherapy
DOIs
Publication statusE-pub ahead of print - Nov 6 2018

Cite this